1. Home
  2. PXLW vs CELU Comparison

PXLW vs CELU Comparison

Compare PXLW & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$5.70

Market Cap

39.1M

Sector

Technology

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.28

Market Cap

34.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
CELU
Founded
1997
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
34.5M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
PXLW
CELU
Price
$5.70
$1.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$14.33
$6.00
AVG Volume (30 Days)
63.8K
31.7K
Earning Date
03-12-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,205,000.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.54
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.67
$1.00
52 Week High
$15.42
$4.35

Technical Indicators

Market Signals
Indicator
PXLW
CELU
Relative Strength Index (RSI) 35.63 49.25
Support Level $5.77 $1.20
Resistance Level $6.08 $1.31
Average True Range (ATR) 0.37 0.07
MACD -0.05 0.01
Stochastic Oscillator 17.27 68.75

Price Performance

Historical Comparison
PXLW
CELU

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: